TY - JOUR
T1 - Extending the Spectrum of EYS-Associated Retinal Disease to Macular Dystrophy
AU - Pierrache, Laurence H M
AU - Messchaert, Muriël
AU - Thiadens, Alberta A H J
AU - Haer-Wigman, Lonneke
AU - de Jong-Hesse, Yvonne
AU - van Zelst-Stams, Wendy A G
AU - Collin, Rob W J
AU - Klaver, Caroline C W
AU - van den Born, L Ingeborgh
PY - 2019/5/1
Y1 - 2019/5/1
N2 - Purpose: To assess the phenotypic variability and natural course of inherited retinal diseases (IRDs) caused by EYS mutations.Methods: Multiethnic cohort study (N = 30) with biallelic EYS variants from a clinical IRD database (retinitis pigmentosa [RP], N = 27; cone-rod dystrophy [CRD], N = 1; and macular dystrophy, N = 2). In vitro minigene splice assay was performed to determine the effect on EYS pre-mRNA splicing of the c.1299+5_1299+8del variant in macular dystrophy patients.Results: We found 27 different EYS variants in RP patients and 7 were novel. The rate of visual field loss of the V4e isopter area was -0.84 ± 0.44 ln(deg2) per year, and the rate of visual acuity loss was 0.75 Early Treatment Diabetic Retinopathy Study letters per year. Ellipsoid zone width was correlated with area of the hyperautofluorescent ring, with rs = 0.78 and P < 0.001. Rate of decline in ellipsoid zone width was -57 ± 17 μm per year (P < 0.01) (n = 14) or -3.69% ± 0.51% from baseline per year (P < 0.001). An isolated CRD patient carried a homozygous EYS variant (c.9405T>A), previously identified in RP patients. Two siblings with macular dystrophy carried compound heterozygous EYS variants: c.1299+5_1299+8del and c.6050G>T. The former was novel and shown to result in skipping of exon 8, and the latter was a known RP variant.Conclusions: We report on EYS-associated macular dystrophy, extending the spectrum of EYS-associated IRDs. We observed heterogeneity between RP patients in age of onset and disease progression. Identical EYS variants were found in cases with RP, CRD, and macular dystrophy. Screening for EYS variants in CRD and macular dystrophy patients might increase the diagnostic yield in previously unsolved cases.
AB - Purpose: To assess the phenotypic variability and natural course of inherited retinal diseases (IRDs) caused by EYS mutations.Methods: Multiethnic cohort study (N = 30) with biallelic EYS variants from a clinical IRD database (retinitis pigmentosa [RP], N = 27; cone-rod dystrophy [CRD], N = 1; and macular dystrophy, N = 2). In vitro minigene splice assay was performed to determine the effect on EYS pre-mRNA splicing of the c.1299+5_1299+8del variant in macular dystrophy patients.Results: We found 27 different EYS variants in RP patients and 7 were novel. The rate of visual field loss of the V4e isopter area was -0.84 ± 0.44 ln(deg2) per year, and the rate of visual acuity loss was 0.75 Early Treatment Diabetic Retinopathy Study letters per year. Ellipsoid zone width was correlated with area of the hyperautofluorescent ring, with rs = 0.78 and P < 0.001. Rate of decline in ellipsoid zone width was -57 ± 17 μm per year (P < 0.01) (n = 14) or -3.69% ± 0.51% from baseline per year (P < 0.001). An isolated CRD patient carried a homozygous EYS variant (c.9405T>A), previously identified in RP patients. Two siblings with macular dystrophy carried compound heterozygous EYS variants: c.1299+5_1299+8del and c.6050G>T. The former was novel and shown to result in skipping of exon 8, and the latter was a known RP variant.Conclusions: We report on EYS-associated macular dystrophy, extending the spectrum of EYS-associated IRDs. We observed heterogeneity between RP patients in age of onset and disease progression. Identical EYS variants were found in cases with RP, CRD, and macular dystrophy. Screening for EYS variants in CRD and macular dystrophy patients might increase the diagnostic yield in previously unsolved cases.
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - DNA Mutational Analysis
KW - Electroretinography
KW - Eye Proteins/genetics
KW - Female
KW - Homozygote
KW - Humans
KW - Macular Degeneration/diagnosis
KW - Male
KW - Middle Aged
KW - Mutation
KW - Pedigree
KW - Phenotype
KW - RNA, Messenger/genetics
KW - Retina/metabolism
KW - Retinitis Pigmentosa/diagnosis
KW - Tomography, Optical Coherence
KW - Visual Acuity
KW - Young Adult
U2 - 10.1167/iovs.18-25531
DO - 10.1167/iovs.18-25531
M3 - Article
C2 - 31074760
SN - 0146-0404
VL - 60
SP - 2049
EP - 2063
JO - Investigative ophthalmology & visual science
JF - Investigative ophthalmology & visual science
IS - 6
ER -